Stratview Research has published a new report titled “Hematology Market” which is segmented by Product Type (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, and Others), by Reagent Type (Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents, and Others), by Application Type (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, and Others), by End-User Type (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
As per the study, the market is likely to witness an impressive CAGR of 5.5% during the forecast period of 2022-2027.
Growing incidences of blood disorders and other diseases, increasing importance of hematological testing in COVID-19 infected patients, rapid technological advancements in hematology, and the emergence of high throughput hematology analyzers are some of the major factors expected to drive the growth of the market during the forecast period.
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
The market is segmented as hematology analyzers, flow cytometers, coagulation analyzers, slide stainers, centrifuges, hemoglobinometers, and others. The market for hematology analyzers is expected to register promising gains during the projected period, owing to the rising prevalence of blood-related disorders, which is driving the demand for hematology tests and their technological advancements.
Which Region is expected to remain the largest market?
North America is estimated to account for the major share of the market during the forecast period, owing to the rising incidences of blood-related disorders and diseases, technological advancements, and an increase in the number of product launches in the region. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Who are the Key Players in the Market?
This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Hematology Market:
- Abbott Laboratorie
- Agilent Technologies Inc
- Bio-Rad Laboratories Inc
- Danaher Corporatio
- Diatron MI PL
- Drew Scientific Grou
- F. Hoffmann-La Roche A
- Fluidigm Corporatio
- Novo Nordisk A/
- PerkinElmer Inc.
Key questions answered by the report
- What is the projected CAGR for revenue from the Hematology Market during the forecast period?
- What would be the market be valued at by 2027?
- What is a major driving factor for growth of the market?
- Which region accounted for largest revenue share in the Hematology Market?
- Which are the major market players?
Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to email@example.com. Or connect with our experts at +1-313-307-4176.
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.